About the Company
inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
18607
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SYNH News
Syneos Health (SYNH) Tops Q1 Earnings, Announces Merger Plan
Syneos Health Inc. SYNH reported first-quarter 2023 adjusted earnings per share (EPS) of 75 cents, which exceeded the Zacks Consensus Estimate by 11.9%.However, the metric declined 25.7% from the ...
Syneos Health Close To Being Acquired For $7B - Elliott, Patient Square and Veritas Investment Consortium Lead Deal
A group of investors, including Elliott Investment Management, Patient Square Capital, and Veritas Capital, is close to acquiring Syneos Health Inc (NASDAQ: SYNH) for more than $7 billion ...
Syneos Health (NASDAQ: SYNH)
Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers ...
Syneos Health®
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization ...
How Syneos Health and VBI Vaccines delivered a new kind of partnership model
Finding the right partner is not always a smooth process, but as Lee Taurman, executive vice president, global head of full-service commercial, Syneos Health, and Jeff Baxter, president and CEO ...
Civitas Resources, Inc. (CIVI)
S&P SmallCap 600 constituent Civitas Resources Inc. (NYSE: CIVI) will replace Syneos Health Inc. (NASD: SYNH) in the S&P MidCap 400, and Hayward Holdings Inc. (NYSE: HAYW) will replace Civitas ...
Odyssey Health, Inc. (ODYY)
2023 / Odyssey Health, Inc. (OTCQB:ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, has selected Syneos Health®, a leading ...
Marcie Doser to lead influencer marketing for Syneos Health US PR
Syneos Health U.S. PR has promoted Marcie Doser to head of influencer marketing. In this new role, Doser will lead the expansion of the PR groups’ influencer marketing services and team, overseeing ...
Syneos Health
In this interview, Dr. Church, the Molecular and Pediatric Pathologist at Boston Children's Hospital, talks to NewsMedical about their work in pediatric oncology, and the need to expand research ...
Loading the latest forecasts...